% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Rhle:267537,
author = {A. Rühle$^*$ and J. Zou$^*$ and M. Glaser and L. Halle and
E. Gkika$^*$ and H. Schäfer$^*$ and A. Knopf and C. Becker
and A.-L. Grosu$^*$ and I. Popp$^*$ and N. Nicolay$^*$},
title = {{T}he influence of antibiotic administration on the
outcomes of head-and-neck squamous cell carcinoma patients
undergoing definitive (chemo)radiation.},
journal = {European archives of oto-rhino-laryngology and head $\&$
neck},
volume = {280},
number = {5},
issn = {0365-5245},
address = {Heidelberg},
publisher = {Springer},
reportid = {DKFZ-2023-00315},
pages = {2605-2616},
year = {2023},
note = {#LA:E055# / 2023 May;280(5):2605-2616},
abstract = {Effects of antibiotic administration on patients'
microbiome may negatively influence cancer outcomes, and
adverse prognoses after antibiotic application have been
demonstrated for cancer patients receiving immune checkpoint
inhibitors. While the microbiome may play an important role
also in head-and-neck squamous cell carcinoma (HNSCC), the
prognostic value of antibiotic treatment here is largely
unknown. We therefore analyzed whether antibiotic
prescription is associated with impaired oncological
outcomes of HNSCC patients undergoing definitive
(chemo)radiation.A cohort of 220 HNSCC patients undergoing
definitive (chemo)radiation between 2010 and 2019 was
analyzed. The influence of antibiotic administration on
locoregional control, progression-free survival (PFS) and
overall survival (OS) was determined using Kaplan-Meier and
Cox analyses.A total of 154 patients were treated with
antibiotics within 30 days before (chemo)radiation
(pretherapeutic) or during (chemo)radiation
(peritherapeutic). While antibiotic prescription was not
associated with age, ECOG, tumor localization or
radiotherapy characteristics, patients treated with
antibiotics had significantly higher tumor stages.
Peritherapeutic antibiotic administration diminished PFS (HR
= 1.397, p < 0.05, log-rank test) and OS (HR = 1.407, p <
0.05), whereas pretherapeutic administration did not.
Antibiotic application was an independent prognosticator for
OS (HR = 1.703, p < 0.05) and PFS (HR = 1.550, p < 0.05) in
the multivariate Cox analysis within the subgroup of
patients aged < 75 years.Peritherapeutic antibiotic usage
was associated with impaired oncological outcomes in HNSCC
patients undergoing (chemo)radiation. Further studies
including microbiome analyses are required to elucidate
underlying mechanisms.},
keywords = {Antibiotics (Other) / Chemoradiation (Other) /
Head-and-neck cancer (Other) / Head-and-neck squamous cell
carcinoma (Other) / Radiotherapy (Other)},
cin = {E055 / FR01},
ddc = {610},
cid = {I:(DE-He78)E055-20160331 / I:(DE-He78)FR01-20160331},
pnm = {315 - Bildgebung und Radioonkologie (POF4-315)},
pid = {G:(DE-HGF)POF4-315},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:36764957},
doi = {10.1007/s00405-023-07868-3},
url = {https://inrepo02.dkfz.de/record/267537},
}